The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)

Clinical Microbiology and Infection

Volumn 19, Issue 6, 2013, Pages 528-536

  Lee, B Y ^a   Singh, A ^a   David, M Z ^b   Bartsch, S M ^a   Slayton, R B ^a   Huang, S S ^c   Zimmer, S M ^a   Potter, M A ^a   Macal, C M ^d   Lauderdale, D S ^b   Miller, L G ^e   Daum, R S ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ARGONNE NATIONAL LABORATORY   (United States)

^e HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

CA MRSA; Community; Cost; Economics; MRSA

Indexed keywords

COTRIMOXAZOLE; NEOSPORIN; PSEUDOMONIC ACID; VANCOMYCIN;

ADULT; AGED; ARTICLE; CELLULITIS; COMMUNITY ASSOCIATED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; DISEASE TRANSMISSION; FEMALE; FOLLICULITIS; HEALTH CARE COST; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; IMPETIGO; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PNEUMONIA; PRIORITY JOURNAL; SOCIOECONOMICS; SOFT TISSUE INFECTION; UNITED STATES;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; COMPUTER SIMULATION; COST OF ILLNESS; HUMANS; INFANT; INFANT, NEWBORN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MODELS, ECONOMIC; STAPHYLOCOCCAL INFECTIONS; UNITED STATES; YOUNG ADULT;

EID: 84876803243     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2012.03914.x     Document Type: Article

References (34)

1. Herold BC, Immergluck LC, Maranan MC et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279: 593-598.
2. Otto M. Community-associated MRSA: a dangerous epidemic. Future Microbiol 2007; 2: 457-459.
3. Moran GJ, Krishnadasan A, Gorwitz RJ et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355: 666-674.
4. Walraven CJ, Lingenfelter E, Rollo J, Madsen T, Alexander DP. Diagnostic and Therapeutic Evaluation of Community-acquired Methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections in the emergency department. J Emerg Med 2012; 42: 392-399.
5. Kluytmans-Vandenbergh MF, Kluytmans JA. Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clin Microbiol Infect 2006; 12 (Suppl 1): 9-15.
6. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010; 23: 616-687.
7. Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis 2007; 13: 236-242.
8. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 2006; 144: 309-317.
9. Tracy LA, Furuno JP, Harris AD, Singer M, Langenberg P, Roghmann MC. Staphylococcus aureus infections in US veterans, Maryland, USA, 1999-2008. Emerg Infect Dis 2011; 17: 441-448.
10. Hota B, Ellenbogen C, Hayden MK, Aroutcheva A, Rice TW, Weinstein RA. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: do public housing and incarceration amplify transmission?Arch Intern Med 2007; 167: 1026-1033.
11. Center of Disease Control and Prevention. Prevention of MRSA infections. Atlanta, 2010. Available from: http://www.cdc.gov/mrsa/prevent/index.html (last accessed 30 April 2012).
12. Purcell K, Fergie J, Peterson MD. Economic impact of the community-acquired methicillin-resistant Staphylococcus aureus epidemic on the Driscoll Children's Health Plan. Pediatr Infect Dis J 2006; 25: 178-180.
13. Taneja C, Haque N, Oster G et al. Clinical and economic outcomes in patients with community-acquired Staphylococcus aureus pneumonia. J Hosp Med 2010; 5: 528-534.
14. Liu C, Bayer A, Cosgrove SE et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52: e18-e55.
15. Human Mortality Database [database on the Internet]. University of California, Berkeley (USA), and Max Planck Institute for demographic research (Germany). 2008. Available from: http://www.mortality.org. (accessed 15 December 2008).
16. Klevens RM, Morrison MA, Nadle J et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298: 1763-1771.
17. Fridkin SK, Hageman JC, Morrison M et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352: 1436-1444.
18. Liu C, Graber CJ, Karr M et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin Infect Dis 2008; 46: 1637-1646.
19. Popovich KJ, David MZ, Grasso AE, Daum RS, Hota B, Lauderdale DS, eds. Abstract #842 Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Skin and Soft Tissue Infections (SSTI) in Chicago, 2005-2008: High-Risk Clusters and Trends in Incidence 49th Annual Meeting Infectious Disease Society of America; 2011 October 22; Boston, MA.
20. David MZ, Glikman D, Crawford SE et al. What is community-associated methicillin-resistant Staphylococcus aureus?J Infect Dis 2008; 197: 1235-1243.
21. Miller LG, Remington FP, Bayer AS et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clin Infect Dis 2007; 44: 471-482.
22. Naimi TS, LeDell KH, Como-Sabetti K et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290: 2976-2984.
23. Malcolm B. The rise of methicillin-resistant staphylococcus aureus in U.S. correctional populations. J Correct Health Care 2011; 17: 254-265.
24. Morrison-Rodriguez SM, Pacha LA, Patrick JE, Jordan NN. Community-associated methicillin-resistant Staphylococcus aureus infections at an Army training installation. Epidemiol Infect 2010; 138: 721-729.
25. David MZ, Mennella C, Mansour M, Boyle-Vavra S, Daum RS. Predominance of methicillin-resistant Staphylococcus aureus among pathogens causing skin and soft tissue infections in a large urban jail: risk factors and recurrence rates. J Clin Microbiol 2008; 46: 3222-3227.
26. Minton TD. Jail inmates at midyear 2010 - statistical tables. Washington, DC: U.S. Department of Justice, Bureau of Justice Statistics, 2011.
27. Molinari NA, Ortega-Sanchez IR, Messonnier ML et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25: 5086-5096.
28. Scharff RL. Health related costs from foodnorne illness in the United States. The Produce Safety Project. Washington, DC: Georgetown University, 2010.
29. Lee GM, Lett S, Schauer S et al. Societal costs and morbidity of pertussis in adolescents and adults. Clin Infect Dis 2004; 39: 1572-1580.
30. Zhang X, Meltzer MI, Pena CA, Hopkins AB, Wroth L, Fix AD. Economic impact of Lyme disease. Emerg Infect Dis 2006; 12: 653-660.
31. Cataldo MA, Taglietti F, Petrosillo N. Methicillin-resistant Staphylococcus aureus: a community health threat. Postgrad Med 2010; 122: 16-23.
32. Baggett HC, Hennessy TW, Rudolph K et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis 2004; 189: 1565-1573.
33. Rybak MJ, LaPlante KL. Community-associated methicillin-resistant Staphylococcus aureus: a review. Pharmacotherapy 2005; 25: 74-85.
34. Lee BY. Digital decision making: computer models and antibiotic prescribing in the twenty-first century. Clin Infect Dis 2008; 46: 1139-1141.